How ten23 Became One of Europe’s Fastest-Growing Drug-Product CDMOs Podcast Por  arte de portada

How ten23 Became One of Europe’s Fastest-Growing Drug-Product CDMOs

How ten23 Became One of Europe’s Fastest-Growing Drug-Product CDMOs

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

What does it really take to build one of Europe’s fastest-growing drug-product CDMOs, and do it with scientific precision, culture-first leadership, and a B-Corp mindset?


This week, in another episode of the Making It in Manufacturing Spotlight Series, we sit down with Hanns-Christian Mahler, CEO & Founder of ten23.

With over 20 years of experience spanning senior roles at Merck, Roche, biopharma development, drug-product strategy, and CDMO leadership, Hanns-Christian brings a rare blend of scientific rigour, sustainability vision, and people-centric leadership.


In this episode, Hanns-Christian covers:


- The origin story of ten23 and why he left big pharma to challenge the CDMO status quo with ten23

- Why ten23 leads with partnership - not execution - and how “asking better questions” is their competitive edge ten23

- ten23’s rapid growth journey: new filling lines, site expansion, headcount growth, and strategic partnerships, like with BD

- The culture behind the company: transparency, autonomy, values-led leadership, and building a truly learning organisation at ten23

- The future of CDMOs: AI adoption with intention, sustainability as a scientific discipline, and what’s next for ten23’s global footprint

- Hanns-Christian also speaks about his partnerships with sustainability-focused companies such as Lio, led by CEO Vladimir Keil, highlighting how these collaborations help drive more responsible and efficient operations.


If you want a masterclass in modern CDMO leadership, rooted in science, innovation, and purpose, this is the episode to watch.


Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com

Youtube: https://www.youtube.com/@life_sciences


Hanns-Christian Mahler

CEO at ten23

LinkedIn: https://www.linkedin.com/in/hanns-christian-mahler/


Thomas McMann

Director - Contracts Division at ARTO

LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/


Timestamps:

00:00 Career Beginnings & ten23

08:18 Challenges with Scaling

14:29 Culture & Leadership Style

20:00 Scientific Rigour vs Sustainability

26:07 Challenges with Geopolitical Issues

29:13 The Future & AI

Hosted on Acast. See acast.com/privacy for more information.

Todavía no hay opiniones